Literature DB >> 19422393

Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma-1 and GABA receptors.

Seo-Yeon Yoon1, Dae-Hyun Roh, Hyoung-Sig Seo, Suk-Yun Kang, Ho-Jae Han, Alvin J Beitz, Jang-Hern Lee.   

Abstract

BACKGROUND AND
PURPOSE: The neurosteroid, dehydroepiandrosterone sulphate (DHEAS) and its non-sulphated form, DHEA, are considered as crucial endogenous modulators of a number of important physiological events. Evidence suggests that DHEAS and DHEA modulate central nervous system-related functions by activating sigma-1 receptors and/or allosterically inhibiting gamma-aminobutyric acid receptor type A (GABA(A)) receptors. As both the sigma-1 receptor and the GABA(A) receptor play important roles in spinal pain transmission, the present study was designed to examine whether intrathecally injected DHEAS or DHEA affect nociceptive signalling at the spinal cord level. EXPERIMENTAL APPROACH: We first determined whether intrathecal (i.t.) DHEA or DHEAS injection was able to affect nociceptive thresholds to peripheral mechanical stimulation and subsequently examined whether this effect was mediated by sigma-1 or the GABA(A) receptors. KEY
RESULTS: The i.t. DHEAS injection dose-dependently decreased the nociceptive threshold to mechanical stimulation, thus producing mechanical allodynia. Moreover, this DHEAS-induced mechanical allodynia was significantly reduced by administration of the sigma-1 receptor antagonist, BD-1047 or the GABA(A) receptor agonist, muscimol. Conversely, i.t. DHEA had no effect on mechanical sensitivity. However, when i.t. DHEA was combined with the GABA(A) receptor antagonist bicuculline, DHEA dose-dependently produced mechanical allodynia similar to that of DHEAS. This effect was blocked by BD-1047 and by muscimol. CONCLUSIONS AND IMPLICATIONS: These findings indicate that i.t. injection of DHEAS produces mechanical allodynia and that the development of this mechanical allodynia is mediated by sigma-1 and GABA(A) receptors. The findings of this study raise several interesting questions for further investigations into the mechanisms underlying neurosteroid modulation of spinal pain transmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422393      PMCID: PMC2707978          DOI: 10.1111/j.1476-5381.2009.00197.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

Review 1.  Sulfated steroids as endogenous neuromodulators.

Authors:  Terrell T Gibbs; Shelley J Russek; David H Farb
Journal:  Pharmacol Biochem Behav       Date:  2006-10-04       Impact factor: 3.533

2.  Guide to Receptors and Channels (GRAC), 3rd edition.

Authors:  S P H Alexander; A Mathie; J A Peters
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

Review 3.  [Neurosteroids and their function].

Authors:  M Bicíková; R Hampl
Journal:  Cas Lek Cesk       Date:  2007

Review 4.  Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microglia.

Authors:  Hanns Ulrich Zeilhofer
Journal:  Int Immunopharmacol       Date:  2007-08-02       Impact factor: 4.932

5.  Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.

Authors:  Hyun-Woo Kim; Young-Bae Kwon; Dae-Hyun Roh; Seo-Yeon Yoon; Ho-Jae Han; Kee-Won Kim; Alvin J Beitz; Jang-Hern Lee
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

Review 6.  Endogenous neuroprotective factors: neurosteroids.

Authors:  Katarzyna Wojtal; Michał K Trojnar; Stanisław J Czuczwar
Journal:  Pharmacol Rep       Date:  2006 May-Jun       Impact factor: 3.024

Review 7.  Managing neuropathic pain.

Authors:  Katherine E Galluzzi
Journal:  J Am Osteopath Assoc       Date:  2007-11

8.  Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors.

Authors:  Zheng-Xiang Cheng; Dan-Mei Lan; Pei-Ying Wu; Yan-Hua Zhu; Yi Dong; Lan Ma; Ping Zheng
Journal:  Exp Neurol       Date:  2007-10-23       Impact factor: 5.330

9.  Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord.

Authors:  Cherkaouia Kibaly; Laurence Meyer; Christine Patte-Mensah; Ayikoe G Mensah-Nyagan
Journal:  FASEB J       Date:  2007-08-24       Impact factor: 5.191

Review 10.  Peripheral neuropathy and neurosteroid formation in the central nervous system.

Authors:  Christine Patte-Mensah; Ayikoe Guy Mensah-Nyagan
Journal:  Brain Res Rev       Date:  2007-06-09
View more
  6 in total

1.  Sigma-1 Receptor Antagonist BD1047 Reduces Allodynia and Spinal ERK Phosphorylation Following Chronic Compression of Dorsal Root Ganglion in Rats.

Authors:  Ji Seon Son; Young Bae Kwon
Journal:  Korean J Physiol Pharmacol       Date:  2010-12-31       Impact factor: 2.016

Review 2.  Gut feelings: the microbiota-gut-brain axis on steroids.

Authors:  Sik Yu So; Tor C Savidge
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-03       Impact factor: 4.052

3.  Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury.

Authors:  Madhavi L Bangaru; Dorothee Weihrauch; Qing-Bo Tang; Vasiliki Zoga; Quinn Hogan; Hsiang-en Wu
Journal:  Mol Pain       Date:  2013-09-10       Impact factor: 3.395

4.  Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation.

Authors:  Shanshan Zhu; Chenchen Wang; Yuan Han; Chao Song; Xueming Hu; Yannan Liu
Journal:  Mediators Inflamm       Date:  2015-11-30       Impact factor: 4.711

5.  Acetaminophen (Paracetamol) Use Modifies the Sulfation of Sex Hormones.

Authors:  Isaac V Cohen; Elizabeth T Cirulli; Matthew W Mitchell; Thomas J Jonsson; James Yu; Naisha Shah; Tim D Spector; Lining Guo; J Craig Venter; Amalio Telenti
Journal:  EBioMedicine       Date:  2018-02-15       Impact factor: 8.143

6.  Partial Agonistic Actions of Sex Hormone Steroids on TRPM3 Function.

Authors:  Eleonora Persoons; Sara Kerselaers; Thomas Voets; Joris Vriens; Katharina Held
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.